CFDE Data Portal | Search SUMO2P13

	Label	Description
	SUMO2P13 Gene (Entity type)	ENSG00000218359 - SUMO2 pseudogene 13
	GSE85880 GSE85881 tretinoin cardiac muscle cell 4 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 10 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 0 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE155031 catechin SH-SY5Y 6 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE234767 GSE234769 dopamine 3 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE234767 GSE234769 dopamine 0 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS

SUMO2P13

ENSG00000218359 - SUMO2 pseudogene 13

GSE85880 GSE85881 tretinoin cardiac muscle cell 4 v 2 human dn

A Gene Set from LINCS

GSE252944 AKT inhibition 10 v 5 human up

A Gene Set from LINCS

GSE100148 EZH2 inhibition 0 v 5 human up

A Gene Set from LINCS

GSE155031 catechin SH-SY5Y 6 v 1 human up

A Gene Set from LINCS

GSE234767 GSE234769 dopamine 3 v 4 human up

A Gene Set from LINCS

GSE234767 GSE234769 dopamine 0 v 4 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.